Guided Therapeutics (GTHP) Other Non-Current Liabilities (2013 - 2026)
Guided Therapeutics (GTHP) posted Other Non-Current Liabilities of $37000.0 for Q4 2025, down 53.16% sequentially from $79000.0 in Q3 2025, and down 68.64% YoY from $118000.0 in Q4 2024.
Guided Therapeutics (GTHP) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Guided Therapeutics has reported Other Non-Current Liabilities for 12 years, with the latest figure at $37000.0 in Q4 2025.
- Quarterly Other Non-Current Liabilities fell 68.64% year-over-year to $37000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37000.0 (down 68.64% YoY) and the FY2025 annual result came in at $37000.0, down 68.64% from the prior year.
- Other Non-Current Liabilities retreated to $37000.0 in Q4 2025 per GTHP's latest filing, from $79000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $118000.0 in Q4 2024 and troughed at -$38000.0 in Q3 2021.
- A 4-year average of $29384.6 and a median of $29000.0 in 2021 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2025: Other Non-Current Liabilities plunged 205.56% in 2021, then jumped 361.54% in 2025.
- Over 4 years, Other Non-Current Liabilities stood at $32000.0 in 2021, then slumped by 115.62% to -$5000.0 in 2022, then soared by 2460.0% to $118000.0 in 2024, then slumped by 68.64% to $37000.0 in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $37000.0, $79000.0, and $60000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Dec 31, 2022 | -5,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | -38,000.00 |
| Jun 30, 2021 | 29,000.00 |
| Dec 31, 2020 | -32,000.00 |
| Sep 30, 2020 | 36,000.00 |
| Jun 30, 2020 | 7.58 Mn |
| Mar 31, 2020 | 1.80 Mn |
| Sep 30, 2019 | 6.10 Mn |
| Jun 30, 2019 | 6.48 Mn |